KC
CTOR

Kepos Capital’s Citius Oncology CTOR Stock Holding History

Kepos Capital’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-225,000
Closed -$2.42M – 270
2023
Q3 		$2.42M Buy
+225,000
New +$2.4M 0.43% 55

Other funds holding CTOR

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Kepos Capital's CTOR Position: Q4 2023 in Review

Kepos Capital sold out of Citius Oncology (CTOR) in Q4 2023, closing a stake of 225,000 shares — an estimated $2.42M sold.

Kepos Capital first reported a position in CTOR in Q3 2023 and held it in 1 quarter. The position peaked at $2.42M in Q3 2023. 23 funds tracked by Wall St. Rank hold CTOR as of Q4 2023.

  • Kepos Capital reported no remaining Citius Oncology position as of Q4 2023 after selling out during the quarter.
  • Kepos Capital sold 225,000 Citius Oncology shares in Q4 2023, an estimated $2.42M.
  • Kepos Capital first reported a position in Citius Oncology in Q3 2023 and held it in 1 quarter.
  • Kepos Capital's Citius Oncology position peaked at $2.42M in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Citius Oncology as of Q4 2023.

Based on Kepos Capital's 13F filing for Q4 2023, filed 12 Feb 2024.